Skip to content
Politically.com Search all
Menu

2026 · 1st Quarter (Jan 1 - Mar 31)

NOVAVAX, INC.

Filed by BROWNSTEIN HYATT FARBER SCHRECK, LLP.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-22 06:26:07 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 15, 2026
Income
$50,000.00
Expenses
Not reported
Filing UUID
986cd7dd-a611-4adb-8d65-ff2e0f38f3ee
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to federal vaccine programs and vaccine regulatory frameworks. FDA funding and advocacy H.R.4121 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

Literal federal measure citations: H.R.4121

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.